+
Site Tour

AV VALVES Summit 2023 Trending Controversies Round 3: TA, TF in TMVR

What have we learned after 3 years of transcatheter mitral valve replacement (TMVR) with Tendyne™ and the future ahead with transfemoral (TF) options? Round 3 of the trending controversies session addresses this topic with Martin Andreas and Lars Søndergaard.

FIND OUT MORE ON AV VALVE SUMMIT 2023:

Watch on Demand videos

Related Videos

AV VALVES 2023: TR – Atrial TR

AV VALVES 2023: Trending Topics – QoL

AV VALVES 2023: Trending Topics – Complexity

AV VALVES 2023:HF and VHD – Patient Management

AV VALVES 2023: TR – Multileaflet Valve

Epic™ HCP testimonial

EACTS 2021: MVR Guidelines update

AV VALVES 2023: Fast Forward 20 Years

AV Valves Summit 2024 | Opening of Day 2

SAFETY IS A JOURNEY | M. Swaans & G. Leurent

Anatomical overview of the AV Valves

AV VALVES 2023: MR – Acute Rupture

EACTS 2022: SMV repair vs replacement

TRENDING TOPICS

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

CONNEXT


HUB
RELATED RESOURCES

Tendyne™: 6-Year Outcomes

bRIGHT study

ESC 2022: FMR

EuroEcho 2021: MR Treatment (Evidence)

CONNEXT


LIVE
RELATED EVENTS

Echo course mitral TEER – procedural approach

Screening Transmission | Mitral focus

Review the Trends | Tricuspid focus

Trending Controversies | AV Valves

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline